The U.S. Food and Drug Administration (FDA) indicated it didn’t expect major shortages in drug manufacturing after a tornado hit a Pfizer pharmaceutical plant in North Carolina on Wednesday.
“We do not expect there to be any immediate significant impacts on supply given the products are currently at hospitals and in the distribution system,” FDA Commissioner Robert Califf said Friday.
He added that the FDA’s initial analysis identified fewer than 10 drugs for which Pfizer’s North Carolina plant is the sole source for the U.S. market.
Pharmaceutical company Pfizer said Friday that most of the damage from the tornado was inflicted on the storage and not the manufacturing area of the plant….